Clinical trial

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Nicky Mehtani, MD, MPHCompletedPhase 2Started Mar 4, 202517 enrolledUnited StatesNCT06538285

Abstract

The goal of this clinical trial is to learn whether it is possible to use intramuscular (IM) ketamine in combination with psychotherapy to treat moderate-to-severe methamphetamine use disorder (MeUD) in publicly insured patients with or at-risk for HIV disease. The main questions it aims to answer are: * Do publicly insured patients find ketamine-assisted psychotherapy feasible and acceptable as a potential treatment for MeUD? * Is IM ketamine safe and tolerable among patients with MeUD? Participants will: * Receive 3 monitored doses of IM ketamine * Have 3 preparation and 4 integration psychotherapy visits * Report their daily amounts of methamphetamine used prior to, during, and up to 3 months following the intervention

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineAddiction

Keywords

HIVMethamphetamine withdrawalKetamine-assisted therapyPsychedelicSexual BehaviorMethamphetamineKetamine-assisted psychotherapyChemsexMethamphetamine Use Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.